🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary endpoint is to determine if ECP induces a decrease in % of tumo...
Status
Recruiting
Location
Emory University School of Medicine
Start Date
2023-04-04
Trial ID
NCT05157581
Treatments Being Tested
The purpose of this study is to examine how effective rituximab or tocilizu...
Status
Active Not Recruiting
Location
Johns Hopkins
Start Date
2020-09-25
Trial ID
NCT04375228
Treatments Being Tested
To evaluate safety, tolerance and efficacy of TASO(TGF-β2 targeting anti-se...
Status
Completed
Location
Seoul National University Hospital
Start Date
2021-03-09
Trial ID
NCT04862767
Treatments Being Tested
This study is a Phase I, single-center, randomized, double-blind, placebo-c...
Status
Completed
Location
SGS clinical pharmacology unit
Start Date
2016-10-18
Trial ID
NCT03102567
The primary objective of the study is to assess the relative bioavailabilit...
Status
Completed
Location
Teva Investigational Site 12141
Start Date
2025-03-10
Trial ID
NCT06911567
Treatments Being Tested
This study is to evaluate the safety, tolerability and immunogenicity of a ...
Status
Completed
Location
Daido Clinic
Start Date
2018-07-12
Trial ID
NCT03571607
Treatments Being Tested
This trial is a longterm follow up of a phase III study of inhaled cyclospo...
Status
Terminated
Location
UCLA School of Medicine
Start Date
2009-12
Trial ID
NCT00938236
Treatments Being Tested
This Phase 3 study is designed to demonstrate the safety and immunogenicity...
Status
Completed
Location
37 Alabama Clinical Therapeutics LLC 52 Medical Park East Drive Suite 203
Start Date
2009-11
Trial ID
NCT01000311
Treatments Being Tested
This research study is testing whether a weekly medication called tirzepati...
Status
Recruiting
Location
Institut de Recherches Cliniques de Montréal
Start Date
2026-05-19
Trial ID
NCT07284511
The objective of the present trial is: * to determine the dose limiting to...
Status
Withdrawn
Location
Gustave Roussy Institute,
Start Date
2012-06
Trial ID
NCT01764009
Treatments Being Tested